Full Press Release Details
at the Canaccord Genuity Musculoskeletal Conference
BELGRADE, MT, February
19, 2014 -- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts
and coatings for medical applications, today announced that its CEO, Dan Goldberger, and CFO, John Gandolfo, will present at the
Canaccord Genuity Musculoskeletal Conference, to be held March 11, 2014 at the Sheraton New Orleans. Bacterin's presentation will
take place Tuesday, March 11, 2014 at 3:10 PM CST.
A live broadcast of the
conference presentation will be available. To access the broadcast, go to the "Investor Info" section of the Company's
website at www.bacterin.com. A replay of the conference presentation will also be available.
About Bacterin International
Bacterin International
Holdings, Inc. (NYSE MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. These
products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone
growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other
Bacterin's Medical Device
division develops, employs, and licenses coatings for various medical device applications. For further information, please visit